Absolute lymphocyte count decreases with disease progression and is a potential prognostic marker for metastatic breast cancer.

Hikari JimboYoshiya HorimotoYumiko IshizukaNoriko NogamiAyana ShikanaiMitsue SaitoJunichiro Watanabe

Published in: Breast cancer research and treatment (2022)

We observed that peripheral blood markers gradually changed with MBC disease progression. Our data suggest that baseline ALC may be a potential prognostic marker after recurrence.

Keyphrases

peripheral blood
metastatic breast cancer
human health
electronic health record
big data
risk assessment
machine learning